HomeMarket NewsRoth MKM Initiates Coverage of Stryker with Buy Rating, Anticipates Strong Recovery...

Roth MKM Initiates Coverage of Stryker with Buy Rating, Anticipates Strong Recovery from COVID-19

Actionable Trade Ideas

always free

Stryker Corporation headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

Roth MKM, an investment bank known for its insightful analysis, has initiated coverage of Stryker (NYSE: SYK) with a buy rating. The bank believes that the medical device company will successfully recover from the challenges posed by COVID-19 and supply chain disruptions.

Stryker is recognized as a premier diversified medical device company with a track record of consistent above-market growth in both its top-line and bottom-line performance. While the pandemic temporarily impacted Stryker’s growth trajectory, Roth MKM sees the company bouncing back strongly with a robust pipeline of new products, positioning it for a return to its previous level of success by 2024.

Roth MKM is particularly impressed by Stryker’s leadership in robotics, with its revolutionary Mako system. This advanced technology is expected to drive market share expansion in hip and knee procedures, solidifying Stryker’s position as the industry leader in this space.

With its comprehensive analysis, Roth MKM has set a price target of $345 for Stryker’s stock, reflecting the bank’s confidence in the company’s future performance.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.